PMID: 9428494Jan 15, 1998Paper

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery

Cancer
A M StapletonT C Thompson

Abstract

This study was designed to evaluate the potential of the molecular and cellular markers p53, Ki-67, and apoptotic index (AI) as adjuncts to the commonly available variables of tumor grade, clinical stage, and serum prostate specific antigen to predict prostate carcinoma recurrence after radical prostatectomy. Representative punch biopsy specimens of prostate carcinoma from whole mount paraffin blocks were evaluated from 47 men who underwent radical prostatectomy. Two groups were defined: those without evidence of prostate carcinoma recurrence after 5 years of follow-up (N = 30) and those with carcinoma recurrence (N = 17). Gleason grade, clustered p53 immunostaining, Ki-67 immunostaining, and AI were determined by standard techniques. All variables tested were associated with disease recurrence by univariate analysis: AI (P = 0.005), clustered p53 immunostaining (P = 0.0070), and Ki-67 immunostaining (P = 0.0390). Using multivariate analyses that included each biomarker with routinely available features, only AI (P = 0.0234) and clustered p53 immunostaining (P = 0.0389) added independent prognostic information (Ki-67 immunostaining, P = 0.1285). In the final logistic regression model that included standard variables with AI and...Continue Reading

References

Jun 3, 1992·Journal of the National Cancer Institute·T VisakorpiJ Isola
Jun 1, 1992·British Journal of Urology·S J ThompsonD E Neal
Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Jan 1, 1992·The Prostate. Supplement·F H SchröderM Pavone-Macaluso
Jun 28, 1991·Cell·G T Williams
Jun 1, 1989·British Journal of Cancer·N BouzubarR I Nicholson
Oct 1, 1988·The Journal of Pathology·W A RaymondJ S Jose
Jan 15, 1983·International Journal of Cancer. Journal International Du Cancer·J GerdesH Stein
Feb 2, 1994·JAMA : the Journal of the American Medical Association·J I EpsteinC B Brendler
Jul 1, 1993·British Journal of Urology·J McLoughlinP D Abel
Jun 15, 1994·Journal of the National Cancer Institute·S G ChiP H Gumerlock
Feb 1, 1995·Seminars in Cancer Biology·R W Craig
Oct 20, 1993·Journal of the National Cancer Institute·N M NavoneC J Conti
Aug 30, 1994·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·G EvanM Bennett
Jan 1, 1994·Journal of Cell Science. Supplement·D M Hockenbery
Sep 30, 1994·Science·H Hermeking, D Eick
May 1, 1993·The American Journal of the Medical Sciences·P J Van VeldhuizenR L Stephens
Jul 1, 1993·The Journal of Urology·P J EffertE T Liu
Mar 1, 1996·British Journal of Urology·E RogersP T Scardino

❮ Previous
Next ❯

Citations

Jul 11, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lawrence TruePeter S Nelson
Apr 25, 2002·Molecular and Cellular Biology·Chengzhen RenTimothy C Thompson
Mar 5, 2003·Human Gene Therapy·Takefumi SatohTimothy C Thompson
Jun 17, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Thorsten SchlommAndreas Erbersdobler
Mar 31, 2012·Archives of Pathology & Laboratory Medicine·George J Netto, Liang Cheng
Mar 21, 2002·Histopathology·D C Brown, K C Gatter
May 5, 2010·Pathology·George J Netto, Jonathan I Epstein
Nov 28, 2015·Surgical Pathology Clinics·George J Netto
Oct 21, 2004·Cancer·David G BostwickBarry Timms
Jan 30, 2004·Cytopathology : Official Journal of the British Society for Clinical Cytology·A BantisP Athanassiadou
Jul 13, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Shigehito MiyamotoHidetoshi Yamanaka
May 16, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Miklós TarjánTibor Tot
Oct 10, 2001·The Urologic Clinics of North America·J I Epstein
Apr 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·David I QuinnRobert L Sutherland
Jan 29, 2002·Journal of Theoretical Biology·Shea N Gardner
Jan 5, 2000·BJU International·J L BurtonJ B Anderson
Sep 21, 2002·The Prostate·Thomas FixemerHelmut Bonkhoff
Nov 1, 2000·The Prostate. Supplement·T C Thompson, G Yang
Nov 9, 2000·BJU International·W D DunsmuirR S Kirby
Mar 11, 2003·Prostate Cancer and Prostatic Diseases·A ErbersdoblerH Huland
Feb 23, 2002·The American Journal of Surgical Pathology·Mark A RubinKenneth J Pienta
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M W KattanP T Scardino
Jul 16, 2005·Scandinavian Journal of Urology and Nephrology. Supplementum·Jonathan I EpsteinRodolfo Montironi
Mar 15, 2018·Frontiers in Immunology·David S Ucker, Jerrold S Levine
Sep 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A V D'AmicoJ P Richie
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A V D'AmicoC N Coleman
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A V D'AmicoJ P Richie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.